World Planet Information.Com
Clear World Information.
Multiple Sclerosis Information
Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis (Business Wire via Yahoo! Finance) THE WOODLANDS, Texas----Opexa Therapeutics, Inc. , a company leading in the development of cell therapies for multiple sclerosis and diabetes, has completed an internal assessment of data from its Phase I/II two year extension study with Tovaxin in patients with MS. Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis (Business Wire via Yahoo! Finance) CAMBRIDGE, Mass. & DUBLIN, Ireland----Biogen Idec and Elan Corporation, plc today announced the two-year anniversary of TYSABRI® as a treatment for relapsing forms of multiple sclerosis , marking the reintroduction of the product in the United States and the first international approval. Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis (Centre Daily Times) Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company leading in the development of cell therapies for multiple sclerosis (MS) and diabetes, has completed an internal assessment of data from its Phase I/II two year extension study with Tovaxin in patients with MS. While confirming the favorable safety and efficacy profile of Tovaxin, further analysis also confirms both the benefit of consecutive ... Biogen Idec reports 2nd-quarter results with Wall Street focused on multiple sclerosis drugs (Canadian Business) July 21, 2008 - 12:44 a.m. NEW YORK (AP) - Drug developer Biogen Idec Inc. reports earnings for the second quarter on Tuesday. The following is a summary of key developments and analyst opinion related to the period. Elan Tysabri numbers exceed expectations (RTÉ News) Elan said today that over 31,800 patients worldwide were receiving its multiple sclerosis (MS) drug Tysabri at the end of June. The figure exceeded the expectations of several analysts. Biogen Idec's 2Q profit rises 11 percent (AP via Yahoo! Finance) Biotechnology company Biogen Idec says profit rose 11 percent on increasing sales of its multiple sclerosis treatments Avonex and Tysabri. Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis (Centre Daily Times) Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced the two-year anniversary of TYSABRI(R) (natalizumab) as a treatment for relapsing forms of multiple sclerosis (MS), marking the reintroduction of the product in the United States (US) and the first international approval. The companies estimate that as of the end of June 2008, more than 31,800 patients worldwide are ... Biogen second-quarter profit rises (Reuters via Yahoo! News) Biogen Idec Inc , which this month fended off activist investor Carl Icahn's attempt to place three hand-picked candidates on the board, reported higher second-quarter profit on Tuesday on strong sales of its multiple sclerosis and cancer drugs. Study To Investigate Link Between Cannabis Compound And Slowing Of Multiple Sclerosis (Medical News Today) The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study. Biogen second-quarter profit rises 11 percent (Reuters via Yahoo! News) Biogen Idec Inc , which this month fended off activist investor Carl Icahn's attempt to place three hand-picked candidates on the board, on Tuesday said second-quarter profit rose 11 percent on strong sales of its multiple sclerosis and cancer drugs. |
|
Education Information Health Information Home Theaters Information Insurance Information Legal Services Information Money Information Property Information Vacations information Shopping Information Travel Information Animals Environment Information Economy Information Crafts Information Investment information History and goverment information Manufacturing industry information People Information Science and Engineering Information Technology Information The World Information |
World Information Categories
All information and links are auto loaded daily to give you updated world information
World Planet Information Information News Archives Planet Information Posts Information Partners Search Partner Directories Contact Us Privacy Statement Site Map
World Planet Information.Com
© Copyright World Planet Information®